Tomorrow · 13:00

We have chosen the topic of "The important first year. Vision 20/20" as a tribute to Mette and Leas ground breaking work in an ever-changing world. Babies develop at exorbitant speed, and largely this is guided by visual inputs. Our goal of this conference is to update us all on the also rapid development of ophthalmological treatment: genetic therapy is now available and preterm born children now rarely go blind due to ROP in Europe, but other health issues threaten vision as very early survival is possible. Surgery for infants is also changing with new methods for treatment in glaucoma, anterior segment and strabismus.


EPOS member BD: EUR 420.0,
EPOS member AD: EUR 510.0,
Non-member BD: EUR 522.0,
Non-member AD: EUR 612.0,
Trainee/resident BD: EUR 336.0,
Trainee/resident AD: EUR 408.0,
Orthoptist, nurse, technician healthcare BD: EUR 336.0,
Orthoptist, nurse, technician healthcare AD: EUR 408.0,
Day ticket: EUR 300.0

Speakers: Kimberley Drenser, Ken Nishal, Darius Hildebrandt